Nanonization of megestrol acetate by liquid precipitation

Industrial and Engineering Chemistry Research

Volumn 48, Issue 18, 2009, Pages 8493-8499

  Zhang, Zhi Bing ^a   Shen, Zhi Gang ^a   Wang, Jie Xin ^a   Zhao, Hong ^a   Chen, Jian Feng ^a   Yun, Jimmy ^b  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b NanoMaterials Technology Pte Ltd   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-SOLVENTS; CHEMICAL GROUP; CONTACT-ANGLE MEASUREMENTS; CRYSTALLINITIES; DISSOLUTION RATES; DRUG DISSOLUTION; DRUG SOLUTIONS; DRYING METHODS; EXPERIMENTAL PARAMETERS; FOURIER TRANSFORM INFRARED; MEAN PARTICLE SIZE; MEAN SIZE; MEGESTROL ACETATE; PRECIPITATION TECHNIQUES; STIRRING SPEED; VOLUME RATIO;

ANGLE MEASUREMENT; CONTACT ANGLE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; LIQUIDS; NANOPARTICLES; PARTICLE SIZE ANALYSIS; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

PRECIPITATION (CHEMICAL);

EID: 70349339183     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie900944y     Document Type: Article

References (34)

1. Deng, Z. Y.; Zhao, R. P.; Dong, L. C.; Wong, G. Characterization of nanoparticles for drug delivery applications. Microsc. Microanal. 2005, 11, 1934-1935.
2. Gregory, E. J.; Cohen, S. C.; Oines, D. W.; Mims, C. H. Megestrol acetate therapy for advanced breast cancer. J. Clin. Oncol. 1985, 3, 155-160.
3. Sikic, B. I.; Scudder, S. A.; Ballon, S. C.; Soriero, O. M.; Christman, J. E.; Suey, L.; Ehsan, M. N.; Brandt, A. E.; Evans, T. L. High dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group. Semin. Oncol. 1986, 13, 26-32.
4. Johnson, D. E.; Babaian, R. J.; Swanson, D. A.; Von Eschbach, A. C.; Wishnow, K.; Tenney, D. Medical castration using megestrol acetate and mini dose estrogens. Urology. 1988, 31, 371-374.
5. Aisner, J.; Parnes, H.; Tait, N.; Hickmam, M.; Forrest, A.; Greco, F. A.; Tchekmedyian, N. S. Appetite stimulation and weight gain with megestrol acetate. Semin. Oncol. 1990, 17, 2-7.
6. Strang, P. The effect of megestrol acetate on anorexia, weight loss and cachaexia in cancer and AIDS patients. Anticancer Res. 1997, 17, 657-662.
7. Shekunov, B. Y.; Chattopadhyay, P.; Seitzinger, J.; Huff, R. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm. Res. 2006, 23, 196-204.
8. Hovey, D.; Pruitt, J.; Ryde, T. Nanoparticulate megestrol formulations. U.S. Patent 20050008707, 2005.
9. Patravale, V. B.; Date, A. A.; Kulkarni, R. M. Nanosuspensions: a promising drug delivery strategy. J. Pharm. Pharmacol. 2004, 56, 827-840.
10. Kesisoglou, F.; Panmai, S.; Wu, Y. Nanosizingsoral formulation development and biopharmaceutical evaluation. AdV. Drug DeliVery ReV. 2007, 5916, 31-44.
11. Van Eerdenbrugh, B.; Van den Mooter, G.; Augustijns, P. Topdown production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int. J. Pharm. 2008, 364, 64-75.
12. Rogers, T. L.; Nelsen, A. C.; Hu, J. H.; Brown, J. N.; Sarkari, M.; Young, T. J.; Johnston, K. P.; Williams, R. O., III. A novel particle engineering technology to enhance dissolution of poorly water-soluble drugs: spray-freezing into liquid. Eur. J. Pharm. Biopharm. 2002, 54, 271-280.
13. Hu, J. H.; Johnston, K. P.; Williams, R. O., III. Rapid dissolving high potency danazol powders produced by spray freezing into liquid process. Int. J. Pharm. 2004, 271, 145-154.
14. Merisko-Liversidge, E.; Liversidge, G. G.; Cooper, E. R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 2003, 18, 113-120.
15. Jacobs, C.; Kayser, O.; Müller, R. H. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int. J. Pharm. 2000, 196, 161-164.
16. Tandya, A.; Dehghani, F.; Foster, N. R. Micronization of cyclosporine using dense gas techniques. J. Supercrit. Fluids 2006, 37, 272-278.
17. 2 antisolvent with enhanced mass transfer. Int. J. Pharm. 2001, 228, 19-31. (Pubitemid 32905362)
18. Matteucci, M. E.; Hotze, M. A.; Johnston, K. P.; Williams, R. O., III. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir 2006, 22, 8951-8959.
19. Zhang, J. Y.; Shen, Z. G.; Zhong, J.; Hu, T. T.; Chen, J. F.; Ma, Z. Q.; Yun, J. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Int. J. Pharm. 2006, 323, 153-160.
20. Park, S. J.; Jeon, S. Y.; Yeo, S. D. Recrystallization of a pharmaceutical compound using liquid and supercritical antisolvents. Ind. Eng. Chem. Res. 2006, 45, 2287-2293.
21. Wang, Z.; Chen, J. F.; Le, Y.; Shen, Z. G.; Yun, J. Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind. Eng. Chem. Res. 2007, 46, 4839-4845.
22. Zhao, H.; Wang, J. X.; Wang, Q. A.; Chen, J. F.; Yun, J. Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor. Ind. Eng. Chem. Res. 2007, 46, 8229-8235.
23. Kashchiev, D. Nucleation: Basic Theory with Applications; Butterworth- Heinemann: Oxford, 2000.
24. Ain-Ai, A.; Gupta, P. K. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int. J. Pharm 2008, 351, 282-288.
25. Rasenack, N.; Steckel, H.; Müller, B. W. Preparation of microcrystals by in situ micronization. Powder Technol. 2004, 143-144, 291-296.
26. Pozarnsky, G. A.; Matijević, E. Preparation of monodisperse colloids of biologically active compounds 1. Naproxen. Colloids Surf. A: Physicochem. Eng. Aspects 1997, 125, 47-52.
27. Pongpeerapat, A.; Wanawongthai, C.; Tozuka, Y.; Moribe, K.; Yamamoto, K. Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture. Int. J. Pharm 2008, 352, 309-316.
28. Dirksen, J. A.; Ring, T. A. Fundamentals of crystallization: kinetic effects on particles size distributions and morphology. Chem. Eng. Sci. 1991, 46, 2389-2427.
29. Horn, D.; Rieger, J. Organic nanoparticles in the aqueous phasestheory, experiment, and use. Angew. Chem. Int. Ed. 2001, 40, 4330-4361.
30. Chen, J. F.; Zhou, M. Y.; Shao, L.; Wang, Y. Y.; Yun, J.; Chew, N. Y. K.; Chan, H. K. Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int. J. Pharm. 2004, 269, 267-274.
31. Nielsen, A. E. Kinetics of Precipitation; Pergamon Press: Oxford, 1964.
32. Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freezedrying of nanoparticles: Formulation, process and storage considerations. AdV. Drug DeliVery ReV. 2006, 58, 1688-1713.
33. Matteucci, M. E.; Paguio, J. C.; Miller, M. A.; Williams, R. O., III; Johnston, K. P. Flocculated amorphous nanoparticles for highly supersaturated solutions. Pharm. Res. 2008, 25, 2477-2487.
34. Sarkari, M.; Brown, J.; Chen, X. X.; Swinnea, S.; Williams, R. O., III; Johnston, K. P. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 2002, 243, 17-31. (Pubitemid 34907954)